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models (models A+M and B+M).  Results: Formalin injections 
resulted in increased apoptotic scores in models A and B. Sa-
line injections increased the number of degenerative cells 
only in model B. Morphine showed protective effects in for-
malin-treated animals of model A+M and saline-treated ani-
mals of model B+M only. In model C, no neurodegenerative 
effects were detected. The protein expression of doublecor-
tin showed a pain-related upregulation in the thalamus re-
gion, whereas protein kinase C epsilon expression was up-
regulated in the cortex.  Conclusions: Severe inflammatory 
pain and pain caused by repetitive injections in neonatal rats 
may cause major changes in the developing brain during the 
first week of life. Morphine may only protect the newborn 
brain against these changes in specific situations. 
 Copyright © 2012 S. Karger AG, Basel 
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 Abstract 
 Background: Untreated exposure to pain in preterm neo-
nates might damage the vulnerable premature brain and al-
ter development. Pain treatment is limited because analge-
sic agents may also have adverse neurodevelopmental con-
sequences in newborns.  Objective: To study the effects of 
neonatal pain and morphine treatment on the developing 
brain in a neonatal rat model.  Methods: Newborn rats were 
randomly assigned to: treatment with formalin injections 
(group 1), saline injections (group 2) and controls receiving 
no injections (group 3). Treatment was given on postnatal 
days 1–3 (model A), 1–5 (model B) and 10–12 (model C). Brains 
were studied histologically and protein expression was eval-
uated (protein kinase C epsilon and doublecortin). Effects of 
preemptive morphine treatment were studied in the same 
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 Introduction 
 Neonatal intensive care treatment is associated with 
frequent and intense moments of distress due to ventila-
tory support and frequent painful procedures  [1, 2] . The 
developing brain of preterm newborns is very vulnerable 
and can be harmed by various environmental factors and 
stressors during a sensitive time of development  [3, 4] . 
Repetitive, untreated pain and distress may harm the pre-
mature brain and have short and long-term effects  [5–7] . 
Although adequate analgesia might prevent effects of 
pain in these vulnerable patients, the use of analgesics is 
still under debate  [1, 8] . Clinical trials have not provided 
sufficient evidence for routine use of morphine in pre-
mature neonates  [9–11] and rodent studies have shown 
widespread apoptotic neurodegeneration in the first 
week of life after administration of many substances with 
GABA A -enhancing and/or NMDA receptor-blocking 
properties  [8, 12] .
 Both neuroprotective and destructive roles of mor-
phine have been suggested in adults. Apoptotic cell death 
of neuronal and glial cells was found only after high dos-
es and prolonged use of morphine  [13] . Both neonatal 
prolonged morphine treatment and repetitive inflamma-
tory pain lead to behavioral changes and abnormal learn-
ing in adult rats, while these effects are reduced when 
pain and morphine treatment are combined  [14, 15] . Pre-
emptive morphine attenuates increased hot plate thresh-
olds, reduced place preference conditioning and reduced 
ethanol preferences in long-term behavioral rodent stud-
ies after neonatal pain exposure  [14, 16] . Interacting ef-
fects of hippocampal gene expression are found after the 
combination of stress and morphine exposure in neona-
tal mice  [17] . 
 The hypothesis of the current study is that exposure to 
pain results in degeneration of cells in the neonatal rat 
brain and that preemptive treatment of these animals 
with morphine protects their brain. The negative effects 
of pain are hypothesized to be absent in older animals. 
The effects of pain and preemptive morphine on the 
brain of newborn and more mature rats were histologi-
cally evaluated. 
 In addition, expression of two important molecular 
markers, protein kinase C epsilon (PKCvarepsilon) and 
doublecortin (DCX), was studied in neonatal rat brains. 
PKC contributes to stabilization of synaptic connections 
 [18] . DCX is necessary for regular neuronal migration 
and differentiation in the cerebral cortex  [19] .
 Methods 
 Outcome 
 The primary outcome of this study is the effect of pain, mor-
phine and their combination on neurodegeneration measured 
as the number of apoptotic cells. Furthermore, the protein ex-
pression of PKCvarepsilon and DCX in different brain regions 
after formalin and saline injections was studied by Western 
blotting.
 Experimental Animal Model 
 One-day-old Wistar rat pups (Tierexperimentelle Einrichtun-
gen der Charité-Universitätsmedizin Berlin, Berlin, Germany) 
were used for these studies. Newborn rats from several litters were 
randomly assigned to different treatment groups. All experiments 
were performed in accordance with the German Animal Welfare 
Act and the guidelines of the Charité-Universitätsmedizin Berlin, 
and were approved by the local animal protection authority in 
Berlin (Landesamt für Gesundheit und Soziales, Berlin, Germa-
ny). The experiments adhered to the guidelines of the committee 
for Research and Ethical Issues of the IASP. 
 In order to investigate age dependency of painful stimuli, 3 
different time points with corresponding experimental models 
were investigated ( table 1 ).
 Newborn rats were randomly assigned to injections of 5   l of 
10% formalin in all 4 paws (group 1, severe pain), injections with 
5   l of 0.9% sodium chloride (saline) in all 4 paws (group 2, mild 
pain) and compared to controls receiving no injections at all 
(group 3).
 Injections were given either from postnatal day 1 to day 3 (P1–
P3; model A) or from day 1 until day 5 (P1–P5; model B). A third 
group of animals received injections at days P10, P11 and P12 
(model C). Animals used for molecular studies received a single 
injection on P3. The rat pups were sacrificed on day P4, P6 or P13, 
respectively. Apart from these treatments, animals from all 
groups received equal care (i.e. daily handling, separation from 
the mother, etc.). 
 Analgesic Treatment with Morphine 
 To evaluate the effects of analgesic therapy on pain-induced 
neuronal degeneration, the preemptive effect of morphine was 
investigated. Animals received morphine sulfate subcutaneously 
(500   g/kg, 0.05 mg morphine/ml solution) 30 min before forma-
lin or saline injections. To evaluate the neurotoxic effects of mor-
phine itself, a control group was included that received only sub-
cutaneous morphine on consecutive postnatal days (models A+M 
and B+M;  table 1 ). For histology and Western blotting, see online 
supplementary material (for all online supplementary material, 
see www.karger.com/doi/10.1159/000341769).
 Statistical Analysis 
 GraphPad Prism version 5.0 (GraphPad Software, La Jolla, 
 Calif., USA) was used to analyze the data. Values are presented as 
means  8 SEM. Groups were compared using one-way and two-
way analysis of variance (ANOVA), nonparametric Kruskal-Wal-
lis tests and exact tests. Statistical significance was determined at 
p  ! 0.05.
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 Results 
 Histology 
 Model A 
 Animals received either formalin (group1, n = 7) or 
saline (group 2, n = 10) in both hind and forepaws during 
days P1, P2 and P3 or no injections (control group 3, n = 
9) (model A, see  table 1 ). At day P4 animals were sacri-
ficed and their brains were processed for histological 
staining as is illustrated in  figure 1 . Mean total apoptotic 
scores were 27,092, 13,044 and 7,625 degenerating cells/
mm 3 for the formalin, saline and control group, respec-
tively ( fig.  2 a). Significantly more apoptotic cells were 
counted in the formalin group and saline group com-
pared to the control group (Mann-Whitney tests: p  ! 
0.001 and p = 0.006). Formalin-treated animals also 
showed higher scores than saline-treated animals (p = 
0.003). Most degenerated cells were found in the lamina 
II of both frontal and parietal cortex of the formalin and 
saline-treated animals ( table 2 ). 
 Model B 
 In model B ( table 1 ) experiments were prolonged until 
the 6th postnatal day (injections day P1–P5). At day P6 
mean total apoptotic scores were 23,506, 25,862 and 
10,092 degenerating cells/mm 3 for the formalin (n = 8), 
saline (n = 11) and control (n = 8) groups, respectively 
( fig. 2 b). Significantly more apoptotic cells were counted 
in the formalin and saline group compared to the control 
group (Mann-Whitney test: p  ! 0.001). No significant 
difference in the number of apoptotic cells were found 
between animals injected with formalin and saline (p = 
0.84). Most degenerated cells were found in the lamina II 
of both frontal and parietal cortex as well as in the cin-
gulum of the formalin- and saline-treated animals ( ta-
ble 2 ).
 Effect of Postnatal Time/Age: Model C 
 Animals were again divided into 3 groups and re-
ceived either 5   l formalin 10% (n = 5) or 5   l saline (n = 
4) in both hind and forepaws during days P10, P11 and 
P12 and were again compared to a control group (n = 4) 
receiving no injections. At day P13, mean total apoptotic 
scores were comparable for the formalin, saline and con-
trol groups, 4,064, 3,759 and 3,162 degenerating cells/
mm 3 , respectively ( fig. 2 c). Compared to the experiments 
in newborn animals (models A and B), the overall apop-
totic scores, also in controls, were lower compared to 
those in newborn animals. 
 Pretreatment with Morphine: Pain Models A+M and 
B+M 
 The effects of pretreatment with 500   g/kg subcuta-
neous morphine before formalin or saline injections, as 
Table 1. T imetable of different histological and molecular experiments
P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 P13
Model A1 X X X ¥
Model A+M2 XM1 XM1 XM1 ¥
Model B3 X X X X X ¥
Model B+M4 XM1 XM1 XM1 XM1 XM1 ¥
Model C5 X X X ¥
Model D6 X
Model D+M7 XM1
T he schedules A–D were used. Different frequencies of in-
jections and variable postnatal ages were examined. X = Inter-
vention; ¥ = perfusion; XM1 = intervention with 500 g mor-
phine/kg.
1 Injection of 5 l formalin 10% (group 1), or injection of 5 l 
0.9% saline (group 2), or controls (no injection, group 3) during 
days P1–3, perfusion at day P4. 2 Animals of model A were pre-
treated with 500 g morphine/kg. Controls received morphine 
once a day without further interventions. 3 Injection of 5 l for-
malin 10% (group 1), or injection of 5 l 0.9% saline (group 2), or 
controls (no injection, group 3) during days P1–5, perfusion at day 
P6. 4 Animals of model B were pretreated with 500 g morphine/
kg. Controls received morphine once a day without further inter-
ventions. 5 Injection of 5 l formalin 10% (group 1), or injection 
of 5 l 0.9% saline (group 2), or controls (no injection, group 3) 
during day P10 –12, perfusion at day P13. 6 Injection of 5 l for-
malin 10% and controls (no injection) on day P3, sacrificed after-
wards on the same day. 7 500 g morphine/kg + injection of 5 l 
formalin 10%, and controls, 500 g morphine/kg on day P3, sac-
rificed afterwards on the same day.
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a b
c d
 Fig. 1. de Olmos cupric silver staining ( a ,  b ) and TUNEL staining ( c ,  d ) of formalin-treated animals ( b ,  d ) com-
pared to control animals ( a ,  c ). Formalin pain induces cell death in the immature rat brain. Neurodegenerative 
changes in the brains of P4 rats who were subjected to subcutaneous formalin injections for 3 days and sacri-
ficed on P4.  b In the injured frontal cortex from an animal subjected to formalin pain over 3 days, degenerated 
cells appear as small dark dots in 70-  m silver-stained sections ( ! 40).  d TUNEL staining performed in a 
10-  m-thick cortical section confirms DNA fragmentation within degenerating cells ( ! 20). 
Table 2. N umber of apoptotic cells in different brain regions for models A and B
Model A Model B
formalin (n = 7) saline (n = 10) control (n = 9) formalin (n = 8) saline (n = 11) c ontrol (n = 8)
mean SEM mean SEM mean SEM mean SEM mean SEM mean SEM
Frontal cortex (lamina II) 10,796 2,375 4,143 696 1,651 334 8,357 868 8,662 535 2,929 514
Frontal cortex (lamina IV) 192 35 163 29 95 28 257 49 244 39 193 53
Cingulate gyrus (lamina II) 2,306 240 1,514 200 1,048 151 1,589 387 2,740 475 1,375 347
Cingulate gyrus (lamina IV) 265 67 163 26 114 23 250 49 262 42 193 30
Nucleus caudatus 106 25 114 24 64 19 425 114 353 76 211 60
Septum 612 154 503 100 381 136 671 106 712 122 450 82
Parietal cortex (lamina II) 7,612 932 3,586 851 2,587 741 7,143 941 8,454 700 2,303 261
Parietal cortex (lamina IV) 155 14 132 21 83 35 193 30 270 40 189 53
Retrosplenial cortex (lamina II) 1,857 584 914 117 476 48 982 186 792 116 518 97
Retrosplenial cortex (lamina IV) 200 28 120 29 146 33 254 36 249 35 100 19
Medial thalamus 359 45 229 37 156 41 639 87 439 45 204 34
Lateral thalamus 555 205 406 100 219 54 550 99 481 89 368 98
Thalamus (V) 216 55 209 50 108 28 282 43 473 50 279 73
Hypothalamus 878 143 360 79 172 60 979 105 860 120 350 33
Subiculum 555 85 260 56 111 22 507 67 465 78 175 37
Hippocampus (CA 1) 253 106 154 27 143 33 329 42 231 47 111 16
Hippocampus (gyrus dentatus) 188 76 137 22 102 31 98 29 174 22 150 28
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well as of receiving morphine therapy without injections, 
are shown in  figure 3 a (receiving injections on days P1–
P3, model A+M) and  figure 3 b (injections on days P1–P5, 
model B+M). 
 For the animals in model A+M (injected during P1–
P3;  fig. 3 a), the mean total apoptotic scores were 10,086, 
9,971 and 11,657 degenerating cells/mm 3 for the animals 
treated with morphine and formalin, morphine and sa-
line, and only morphine, respectively. Pretreatment with 
morphine reduced total apoptotic scores in the formalin 
group (p = 0.01), but not in the control and saline groups 
(p = 0.065 and p = 0.71). Brains of animals in model B+M 
(injected during P1–P5) showed mean total apoptotic 
scores of 17,371, 19,942 and 11,908 degenerating cells/
mm 3 for the animals treated with morphine and forma-
lin, morphine and saline, and morphine alone, respec-
tively. In this model, morphine significantly reduced the 
number of degenerating cells only in animals receiving 
morphine prior to saline injections. 
 The results of the cupric silver staining were acknowl-
edged by TUNEL-staining ( fig. 1 ). 
 Protein Biochemistry 
 PKCvarepsilon and DCX protein expressions were 
studied in the cortex and thalamus ( table 1 ). After forma-
lin injections on day 3 (model D), PKCvarepsilon was up-
regulated in cortices after 2 h. Prior subcutaneous injec-
tion of morphine (model D+M) resulted in a significant 
reduction of cortical PKCvarepsilon concentration com-
pared to the formalin group ( fig. 4 ). 
 DCX expression was only influenced in the thalamus 
where protein concentrations were increased by painful 
stimuli at 2 and 6 h after formalin injections. Again, mor-
phine injections prevented the rise in DCX concentration 
in the thalamus ( fig. 4 ).
 Discussion 
 Both neonatal pain and opioid exposure are important 
factors that may influence central nervous system path-
ways and cell survival. In the current study we show cell 
death in neonatal rat brains subjected to mild and severe 
pain. This damage probably consists of neuronal apopto-
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 Fig. 2. Total apoptotic scores in the brain of animals at different 
ages. Model A ( a ) at day P4 after injections with formalin or saline 
at day P1 until day P3 compared to controls (n = 7–10), model B 
( b ) at day P6 after injections with formalin or saline at day P1 un-
til day P5 compared to controls (n = 8–11 per group), and mod-
el C ( c ) at day P13 after injections with formalin or saline at day 
P10 until day P12 compared to controls (n = 4–5).  * *  p = 0.006; 
 * * *  p  ! 0.001; Mann-Whitney U nonparametric tests. 
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sis as shown by TUNEL and de Olmos cupric silver stain-
ing  [20] . Severe pain also altered the expression of the 
neurodevelopmentally important proteins PKCvarepsi-
lon and DCX. Comparable to our results, Juul et al. [17] 
showed an effect between the severity of stress and the 
amount of gene expression in the neonatal murine hip-
pocampus. This indicates a dose-dependant relationship 
between distress and the neuronal damage. 
 Interestingly, morphine pretreatment was only related 
to decreased neurological damage in some of the experi-
ments. Morphine seems to protect against cell degenera-
tion from severe 3 days repeated formalin pain and 5 days 
repetitive mild pain from saline injections. Morphine 
could not significantly decrease severe formalin pain 
 after 5 days. Morphine might protect the brain up to a 
certain limit. Previous animal studies also showed inter-
active effects between morphine and pain  [14–17] . Mor-
phine seems to downregulate specific stress-related 
changes in gene expression that protect the cell against 
apoptosis  [13] . In older human infants, the beneficial ef-
fect of anesthesia for surgery was established decades ago 
 [21] . There is, however, no human clinical evidence of 
long-term beneficial effects of morphine administered 
for daily neonatal care. In fact, the scant research in hu-
man preterm neonates suggests that continuous preemp-
tive analgesia may have adverse effects  [5, 9–11] . Opioids 
seem to have different effects in the presence or absence 
of pain. In rodent studies, where animals were known to 
be in pain, morphine prevented some changes to the neo-
natal nociceptive system caused by pain  [14, 16] , while in 
the absence of pain, opioids have been found to be neu-
rotoxic and can impair cognitive and behavioral develop-
ment  [22, 23] .
 Opioids and endorphins probably play an important 
role in modulation and regulation of neuronal differ-
entiation and survival. PKCvarepsilon participates in
the neuroprotective effects of morphine  [24] , where-
as PKCvarepsilon overexpression increases NMDA-re-
ceptor activity leading to excitotoxic cell death  [25] . In 
our study, cortical PKCvarepsilon was acutely increased 
by painful stimuli and then dropped to the initial level. 
PKCvarepsilon expression was lower in the morphine-
treated animals. DCX showed a steep rise in concentra-
tion in the thalamus region after severe prolonged pain. 
This DCX overexpression may reflect diffuse migration 
and an abnormal differentiation of neuroblasts  [19, 26] , 
but may also be a protective reaction as a response to 
pain-related degeneration of neurons  [27] . Morphine pre-
treatment again reduced the DCX levels. This supports 
the potential protective role of preemptive analgesia in 
newborn infants. However, further research is needed to 
elucidate the underlying mechanisms.
 Our study has some important limitations. It is diffi-
cult to translate the animal data to the human preterm 
neonate. Pain did not increase neurodegeneration in rats 
at older ages, suggesting an age-dependent effect. Al-
though the brain of newborn rats is probably comparable 
to premature born humans, the period of brain spurt oc-
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 Fig. 3. The effect of preemptive morphine in saline- and for malin-
treated animals compared to controls on apoptotic scores.  a Mor-
phine injection reduces the amount of degenerated neurons in-
duced by formalin pain at P4 (model A+M).  b This morphine ef-
fect after 5 days of painful injections (P1–P5) is less impressive 
and not even significant for formalin pain-treated animals (mod-
el B+M). The white bars represent animals who received addi-
tional morphine treatment.  * p = 0.02;  * * p = 0.01; two-way ANO-
VA/Mann-Whitney test (n = 5). 
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curs in different species at different times relative to birth 
 [28] . 
 Formalin-induced pain is a well-worked out nocicep-
tive model in the infant rodent  [14] . Unfortunately, we did 
not measure the amount of pain and cannot discriminate 
between pain, stress and inflammation. Formalin injec-
tions led to a clear nociceptive reaction. After repetitive 
injections, a severe ongoing inflammation of the paws 
was seen. After prolonged injections (model B), mor-
phine did not decrease the apoptotic scores any more. 
The formalin model simulates ongoing severe distress 
and probably overestimates the amount of distress related 
to routine neonatal intensive care unit treatment  [29] . 
 Repetitive saline injections probably are a more suit-
able model for human neonates receiving repetitive pain-
ful procedures. Prolonged use of repetitive saline injec-
tions showed an enormous potential impact on the devel-
oping brain. As an isotonic, sodium chloride solution is 
not expected to have any toxic effects; neuronal degen-
eration is caused by repeated pain induced by the injec-
 Fig. 4. PKCvarepsilon and DCX protein expression levels.  a For-
malin injection leads to a quick rise in PKCvarepsilon concentra-
tion after 2 h in the cortex of neonatal rats (model D).  b The injec-
tion of morphine prior to the injection of formalin results in a 
reduction of PKCvarepsilon concentration in the neonatal rat cor-
tex after 2, 6 and 12 h (model D).  c Thalamic  DCX levels in for-
malin-treated neonatal rats compared to controls. DCX is influ-
enced by painful events. The formalin pain leads to a steep rise 
after 2 h, and is still elevated after 6 h compared to control ani-
mals.  d Effect of morphine treatment on DCX in neonatal rats 
after formalin-induced pain. As PKCvarepsilon, DCX protein ex-
pression is lowered due to morphine exposure prior to formalin 
injections.  b ,  d The white bars represent animals who received 
additional morphine treatment.  * p  ! 0.05;  * * p  ! 0.01;  * * * p  ! 
0.001; one-way ANOVA (n = 5 per group). 
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tions itself or by the inflammatory response to the injec-
tions. Consistent with the only human study of neonatal 
pain in relation to brain microstructure development in 
preterm humans  [3] , this indicates the extreme vulnera-
bility of the premature brain and the potential danger of 
frequently repeated pain and stressful stimuli in prema-
ture neonates.
 Even today, neonatal intensive care treatment is relat-
ed to inescapable frequent painful procedures and dis-
tress, often without analgesic pharmacological therapy 
 [1, 2, 29] . Clinical trials have not shown beneficial effects, 
but effects such as hypotension and prolonged ventilation 
of routinely used morphine during artificial ventilation 
 [5, 9–11] . Therefore, opioid treatment is not standard of 
care nowadays in ventilated newborns. Current neonatal 
pain treatment focuses on individualized pharmacologi-
cal and nonpharmacological approaches. Our data pro-
vides evidence that morphine has a neuroprotective ef-
fect when given prior to painful stimuli and in that way 
encourages the clinical use of opioids if a newborn is 
known to suffer from pain. As opioids seem to have dif-
ferent effects in the presence or absence of pain, one of the 
major clinical challenges is to identify when a preterm 
infant is actually in pain. It is of great importance for both 
clinicians and researchers to further explore this impor-
tant area of research.
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